David George Kelly's Insider Trades & SAST Disclosures
David George Kelly's most recent trade in Iterum Therapeutics Plc was a trade of 647,059 Share Option (Right to Buy) done . Disclosure was reported to the exchange on June 15, 2022.
Add Superstar Alert
Share
Note
This is a custom search result for pattern David George Kelly.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Iterum Therapeutics Plc | David George Kelly | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2022 | 647,059 | 647,059 | - | - | Share Option (Right to Buy) | |
| Iterum Therapeutics Plc | David George Kelly | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jun 2021 | 64,706 | 64,706 | - | - | Stock Option (Right to Buy) | |
| Iterum Therapeutics Plc | David George Kelly | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Jun 2020 | 11,406 | 0 | - | - | Restricted Stock Units | |
| Iterum Therapeutics Plc | David George Kelly | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Jun 2020 | 11,406 | 37,108 (0%) | 0% | - | Ordinary Shares | |
| Iterum Therapeutics Plc | David George Kelly | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2020 | 62,840 | 62,840 | - | - | Stock Option (Right to Buy) |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges